Want to join the conversation?
$ESS expects 3Q16 core FFO per share of $2.73-2.79. The company narrowed FY16 core FFO per share guidance to $10.90-11.06 from prior range of $10.72-11.12. $ESS tightened the range of same-property revenue growth to 6.6-7% from prior range of 6.5-7.5%. The company lifted operating expenses growth outlook to 3.5-4% from prior range of 3.25-4.25%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?